Pure Global AI
NCT06065514Recruiting

The Role of Inflammation in Myocardial Infarction

The Complex Role of the Inflammation Response Following an Acute Myocardial Infarction: the INFINITY (INFlammatIoN amI sTudY)
Nicosia General HospitalClinicalTrials.gov
Verified
Study focus
Disease/Condition
Myocardial Infarction
Study type
Observational
Sponsor & location
Primary sponsor
Nicosia General Hospital
Location
Nicosia,Thessaloniki,Thessaloniki,Thessaloniki, Cyprus,Greece
Timeline & enrollment
Phase
N/A
Start date
Aug 24, 2023
End date
May 30, 2025
Enrollment
120 participants
Primary outcome

Incidence of Mortality

Summary

The aim of this research is to study the prognostic role of a selected combination of
 cytokines and adipokines in patients with myocardial infarction, as well as to determine
 their role in the development of adverse cardiac remodeling.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedOld myocardial infarctionSubsequent myocardial infarctionObservation for suspected myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06065514
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06065514 through Pure Global AI's free database. This phase not specified trial is sponsored by Nicosia General Hospital and is currently Recruiting. The study focuses on Myocardial Infarction. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.